Why do jg cells secrete renin

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Juxtaglomerular (JG) cells secrete renin primarily in response to decreased blood pressure or sodium levels in the distal tubule. These specialized smooth muscle cells in the afferent arteriole walls detect reduced stretch via baroreceptors and respond to signals from macula densa cells. Renin secretion initiates the renin-angiotensin-aldosterone system (RAAS), which increases blood pressure through vasoconstriction and sodium retention. This mechanism helps maintain blood pressure within the normal range of 90-120 mmHg systolic.

Key Facts

JG cells are located in the walls of afferent arterioles near the glomerulus in nephrons
Renin secretion increases when renal perfusion pressure drops below approximately 90 mmHg
The RAAS system activated by renin can increase blood pressure by 10-20 mmHg within minutes
JG cells respond to three main stimuli: decreased blood pressure, decreased sodium chloride delivery to macula densa, and sympathetic nervous system activation via β1-adrenergic receptors
Renin converts angiotensinogen to angiotensin I, which is then converted to angiotensin II by angiotensin-converting enzyme (ACE)

Overview

Juxtaglomerular (JG) cells are specialized smooth muscle cells located in the walls of the afferent arterioles of nephrons, first described in detail by Goormaghtigh in 1932. These cells form part of the juxtaglomerular apparatus, which also includes macula densa cells of the distal tubule and extraglomerular mesangial cells. The discovery of renin dates back to 1898 when Finnish physiologist Robert Tigerstedt and his student Per Bergman identified this proteolytic enzyme in rabbit kidney extracts. JG cells typically measure 10-15 micrometers in diameter and contain prominent secretory granules storing prorenin and renin. Their strategic location allows them to monitor blood pressure changes directly while communicating with macula densa cells that sense sodium chloride concentration in tubular fluid. This anatomical arrangement creates a sophisticated feedback system that has been evolutionarily conserved across mammalian species to maintain circulatory homeostasis.

How It Works

JG cells secrete renin through a complex regulatory mechanism involving multiple inputs. When systemic blood pressure decreases, reduced stretch of afferent arteriole walls activates intrinsic baroreceptors in JG cells, triggering renin release. Simultaneously, decreased sodium chloride delivery to the macula densa (specialized tubular cells adjacent to JG cells) stimulates prostaglandin E2 and nitric oxide production, which further promotes renin secretion. Additionally, sympathetic nervous system activation via β1-adrenergic receptors on JG cells increases cyclic AMP levels, enhancing renin synthesis and release. Once secreted, renin (a 340-amino acid aspartyl protease) cleaves angiotensinogen (a 452-amino acid α2-globulin produced by the liver) to form angiotensin I. This decapeptide is then converted to angiotensin II by angiotensin-converting enzyme (ACE) primarily in pulmonary capillaries. Angiotensin II causes vasoconstriction and stimulates aldosterone secretion, completing the RAAS cascade that restores blood pressure and sodium balance.

Why It Matters

The renin secretion by JG cells is clinically significant because dysregulation contributes to hypertension, affecting approximately 1.28 billion adults worldwide according to WHO 2021 data. Pharmaceutical interventions targeting this system include ACE inhibitors (like lisinopril) and angiotensin receptor blockers (like losartan), which collectively represent over 20% of antihypertensive prescriptions. In renal artery stenosis, excessive renin secretion can cause secondary hypertension that may be corrected through angioplasty. The RAAS system also plays crucial roles in heart failure management, with drugs like sacubitril/valsartan combining neprilysin inhibition with angiotensin receptor blockade. Beyond cardiovascular medicine, understanding JG cell function helps diagnose conditions like Bartter syndrome (characterized by hyperreninemia) and guides treatment for hepatorenal syndrome where RAAS activation contributes to renal vasoconstriction.